Thermo Fisher Scientific Inc (TMO) Files 10-K for the Fiscal Year Ended on December 31, 2018

GuruFocus.com
0
In this article:

- By insider

Thermo Fisher Scientific Inc (TMO) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals. Thermo Fisher Scientific Inc has a market cap of $104.32 billion; its shares were traded at around $259.12 with a P/E ratio of 35.73 and P/S ratio of 4.32. The dividend yield of Thermo Fisher Scientific Inc stocks is 0.27%. Thermo Fisher Scientific Inc had annual average EBITDA growth of 13.80% over the past ten years. GuruFocus rated Thermo Fisher Scientific Inc the business predictability rank of 5-star.


For the last quarter Thermo Fisher Scientific Inc reported a revenue of $6.5 billion, compared with the revenue of $6 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $24.4 billion, an increase of 16.4% from last year. For the last five years Thermo Fisher Scientific Inc had an average revenue growth rate of 11.5% a year.

The reported diluted earnings per share was $7.24 for the year, an increase of 29.5% from previous year. Over the last five years Thermo Fisher Scientific Inc had an EPS growth rate of 12.8% a year. The Thermo Fisher Scientific Inc had a decent operating margin of 15.74%, compared with the operating margin of 14.65% a year before. The 10-year historical median operating margin of Thermo Fisher Scientific Inc is 12.70%. The profitability rank of the company is 8 (out of 10).

At the end of the fiscal year, Thermo Fisher Scientific Inc has the cash and cash equivalents of $2.1 billion, compared with $1.3 billion in the previous year. The long term debt was $17.7 billion, compared with $18.9 billion in the previous year. The interest coverage to the debt is 5.7. Thermo Fisher Scientific Inc has a financial strength rank of 6 (out of 10).

At the current stock price of $259.12, Thermo Fisher Scientific Inc is traded at 64.7% premium to its historical median P/S valuation band of $157.29. The P/S ratio of the stock is 4.32, while the historical median P/S ratio is 2.62. The intrinsic value of the stock is $132.66 a share, according to GuruFocus DCF Calculator. The stock gained 18.97% during the past 12 months.

Directors and Officers Recent Trades:

  • Senior Vice President Gregory J. Herrema sold 5,400 shares of TMO stock on 02/19/2019 at the average price of $251.51. The price of the stock has increased by 3.03% since.

  • VP & Chief Accounting Officer Peter E Hornstra sold 5,920 shares of TMO stock on 02/15/2019 at the average price of $250. The price of the stock has increased by 3.65% since.

For the complete 20-year historical financial data of TMO, click here.

This article first appeared on GuruFocus.


Advertisement

Recommended Stories